DEV — test website with test data. Orders here are not real and nothing is shipped or charged.

Tech support 866-350-1500

Pay by PO: enter it at checkout

Neuromics

Primary Antibody · Mouse IgG

APP 228

Cited in 1 paper
Species
Human
Applications
IHC

Published with this product (1)

Description

Alzheimer's disease, the most common cause of dementia in the elderly, exists in both familial and sporadic forms. Genetic studies have identified three genes; beta-amyloid precursor protein (APP), Presenilin 1 and Presenilin 2 which, when mutated, can cause familial forms of Alzheimer's disease. APP and APP-like proteins are transmembrane glycoproteins with a similar modular domain structure.

APP-228 has been raised to the extracellular portion of APP between the Kunitz protease inhibitor domain and the beta amyloid region. This region shows the least homology with the APP-like proteins. APP-228 and does not cross-react with APP-like proteins. APP reacts with large pyramidal cells as well as smaller neurons, astrocytes and microglia. APP 228 reacts with late-stage neurofibrillary tangle-bearing neurons, neuritic processes surrounding senile plaques and neuropil threads in gray matter of Alzheimer's disease brain. Unmasking in 1mM EDTA (pH8.0) in a pressure cooker may be required for up to 5 minutes in order for this APP-228 to work optimally.


A-Beta proteolysis by TTR is KPI-sensitive.
A- A-Beta incubated with TTR (A-Beta+TTR) shows a weaker A-Beta monomer band as compared to A-Beta alone (A-Beta), indicative of proteolysis, as analyzed by SDS-PAGE electrophoresis followed by western blot. Pre-incubation of TTR with pefabloc (A-Beta+(TTR+pefabloc)) and with an αAPP peptide containing the KPI domain (A-Beta+(TTR+KPI+−APP)) inhibits TTR proteolytic activity, whereas the αAPP peptide without the KPI domain (A-Beta+(TTR+KPI−−APP)) facilitates proteolysis. B- % of inhibition of TTR proteolysis by quantification of band intensity in A. C- Ultrastructural analysis by TEM of preparations incubated for 15 hours, as described in Materials and Methods. TTR inhibited A-Beta aggregation as compared with A-Beta incubated alone (upper panels). Pre-incubation of TTR with αAPP peptide containing the KPI domain (A-Beta+(TTR+KPI+−APP)) abrogated TTR ability to avoid A-Beta aggregation, whereas αAPP lacking the KPI domain (A-Beta+(TTR+KPI−−APP)) did not affected TTR activity (lower panels). Scale bar=500 nm. PLoS ONE. 2008; 3(8): e2899. Published online 2008 August 6. doi: 10.1371/journal.pone.0002899.

Human cortex, Alzheimer's disease: immunohistochemical staining using amyloid precursor protein-228. Note intense staining of neurofibrillary tangles and senile plaques. Paraffin section
Human cortex, Alzheimer's disease: immunohistochemical staining using amyloid precursor protein-228. Note intense staining of neurofibrillary tangles and senile plaques. Paraffin section
APP 228

Related products

2 more in Primary Antibody

For research use only. Not for diagnostic or clinical use.